Dose-dependent effects of prenatal exposure of pioglitazone, the PPARγ agonist, on the hippocampus development and learning and memory performance of rat offspring
 
Yazarlar (1)
Doç. Dr. Dilek SAĞIR Sinop Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Toxicology and Applied Pharmacology (Q1)
Dergi ISSN 0041-008X Dergi Bilgileri (2021)
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 06-2021
Kabul Tarihi Yayınlanma Tarihi 01-06-2021
Cilt / Sayı / Sayfa 421 / 1 / 1–7 DOI 10.1016/j.taap.2021.115544
Makale Linki https://www.sciencedirect.com/science/article/pii/S0041008X21001514
UAK Araştırma Alanları
Hücre Biyolojisi
Özet
It is known that pioglitazone, defined as a PPARγ agonist, has neuron-protective properties in nervous system disorders. The aim of this study is to investigate the effects of pioglitazone administration at different doses during prenatal period on the neurons, glial cells and learning-memory levels in the hippocampus of rat offspring.Pregnant rats were divided into three groups; Low-Dose Pioglitazone (LDP), High-Dose Pioglitazone (HDP) and control (C) (n = 3). Pregnant rats in the HDP and LDP groups were given pioglitazone at 30 mg/kg and 5 mg/kg doses, respectively, by gavage once a day during their pregnancy. No procedure was applied to the rats in the control group. Morris water tank test was applied to offspring obtained from postnatal 24th to 28th day. The offspring were sacrificed on the 29th postal day and their brain tissues removed. Stereological, histopathological and immunohistochemical techniques …
Anahtar Kelimeler
Glial fibrillar acidic protein (GFAP) | Hippocampus | Learning and memory | Neurotoxicity | Pioglitazone | PPARγ